ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MNMD Mind Medicine MindMed Inc

9.7001
-0.0799 (-0.82%)
Pre Market
Last Updated: 08:00:03
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,279
Bid Price 9.70
Ask Price 9.76
News -
Day High

Low
2.41

52 Week Range

High
12.22

Day Low
Company Name Stock Ticker Symbol Market Type
Mind Medicine MindMed Inc MNMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0799 -0.82% 9.7001 08:00:03
Open Price Low Price High Price Close Price Prev Close
9.78
Trades Volume Avg Volume 52 Week Range
51 2,279 - 2.41 - 12.22
Last Trade Time Type Quantity Stock Price Currency
08:25:23 4 $ 9.75 USD

Mind Medicine MindMed (MNMD) Options Flow Summary

Overall Flow

Bullish

Net Premium

104k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Mind Medicine MindMed Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.89M 41.33M - 0 -95.73M -2.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Mind Medicine MindMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MNMD Message Board. Create One! See More Posts on MNMD Message Board See More Message Board Posts

Historical MNMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.9511.009.5110.221,604,654-1.25-11.41%
1 Month9.8912.228.973210.322,304,232-0.1899-1.92%
3 Months3.8812.223.508.702,309,7295.82150.00%
6 Months2.8112.222.417.541,370,2696.89245.20%
1 Year3.1412.222.416.59930,4006.56208.92%
3 Years85.300586.552.1227.893,288,820-75.60-88.63%
5 Years85.300586.552.1227.893,288,820-75.60-88.63%

Mind Medicine MindMed Description

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Your Recent History

Delayed Upgrade Clock